The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8

COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP FIGI (to the nearest dollar) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ISHARES INC CORE MSCI EMKT 46434G103   17,798,767 361,103 SH   SOLE   361,103 0 0
DUOLINGO INC CL A COM 26603R106   52,816,330 369,500 SH   SOLE   369,500 0 0
NEUBASE THERAPEUTICS INC. COM 64132K102   87,834 46,970 SH   SOLE   46,970 0 0
PREDICTIVE ONCOLOGY INC. COM NEW 74039M200   50,340 10,358 SH   SOLE   10,358 0 0
VERA THERAPEUTICS INC. CL A 92337R101   257,763 16,060 SH   SOLE   16,060 0 0
INNSUITES HOSPITALITY TRUST SH BEN INT 457919108   23,900 10,000 SH   SOLE   10,000 0 0